RATIONALE: In the failing heart, persistent β-adrenergic receptor activation is thought to induce myocyte death by protein kinase A (PKA)-dependent and PKA-independent activation of calcium/calmodulin-dependent kinase II. β-adrenergic signaling pathways also are capable of activating cardioprotective mechanisms. OBJECTIVE: This study used a novel PKA inhibitor peptide to inhibit PKA activity to test the hypothesis that β-adrenergic receptor signaling causes cell death through PKA-dependent pathways and cardioprotection through PKA-independent pathways. METHODS AND RESULTS: In PKA inhibitor peptide transgenic mice, chronic isoproterenol failed to induce cardiac hypertrophy, fibrosis, and myocyte apoptosis, and decreased cardiac function. In cultured adult feline ventricular myocytes, PKA inhibition protected myocytes from death induced by β1-adrenergic receptor agonists by preventing cytosolic and sarcoplasmic reticulum Ca(2+) overload and calcium/calmodulin-dependent kinase II activation. PKA inhibition revealed a cardioprotective role of β-adrenergic signaling via cAMP/exchange protein directly activated by cAMP/Rap1/Rac/extracellular signal-regulated kinase pathway. Selective PKA inhibition causes protection in the heart after myocardial infarction that was superior to β-blocker therapy. CONCLUSIONS: These results suggest that selective block of PKA could be a novel heart failure therapy.
RATIONALE: In the failing heart, persistent β-adrenergic receptor activation is thought to induce myocyte death by protein kinase A (PKA)-dependent and PKA-independent activation of calcium/calmodulin-dependent kinase II. β-adrenergic signaling pathways also are capable of activating cardioprotective mechanisms. OBJECTIVE: This study used a novel PKA inhibitor peptide to inhibit PKA activity to test the hypothesis that β-adrenergic receptor signaling causes cell death through PKA-dependent pathways and cardioprotection through PKA-independent pathways. METHODS AND RESULTS: In PKA inhibitor peptide transgenic mice, chronic isoproterenol failed to induce cardiac hypertrophy, fibrosis, and myocyte apoptosis, and decreased cardiac function. In cultured adult feline ventricular myocytes, PKA inhibition protected myocytes from death induced by β1-adrenergic receptor agonists by preventing cytosolic and sarcoplasmic reticulum Ca(2+) overload and calcium/calmodulin-dependent kinase II activation. PKA inhibition revealed a cardioprotective role of β-adrenergic signaling via cAMP/exchange protein directly activated by cAMP/Rap1/Rac/extracellular signal-regulated kinase pathway. Selective PKA inhibition causes protection in the heart after myocardial infarction that was superior to β-blocker therapy. CONCLUSIONS: These results suggest that selective block of PKA could be a novel heart failure therapy.
Authors: Atsushi Sanbe; James Gulick; Mark C Hanks; Qiangrong Liang; Hanna Osinska; Jeffrey Robbins Journal: Circ Res Date: 2003-03-06 Impact factor: 17.367
Authors: Laurel A Grisanti; Jennifer A Talarico; Rhonda L Carter; Justine E Yu; Ashley A Repas; Scott W Radcliffe; Hoang-Ai Tang; Catherine A Makarewich; Steven R Houser; Douglas G Tilley Journal: J Mol Cell Cardiol Date: 2014-02-22 Impact factor: 5.000
Authors: Sribalaji Lakshmikanthan; Bartosz J Zieba; Zhi-Dong Ge; Ko Momotani; Xiaodong Zheng; Hayley Lund; Mykhaylo V Artamonov; Jason E Maas; Aniko Szabo; David X Zhang; John A Auchampach; David L Mattson; Avril V Somlyo; Magdalena Chrzanowska-Wodnicka Journal: Arterioscler Thromb Vasc Biol Date: 2014-05-01 Impact factor: 8.311
Authors: Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang Journal: Circ Res Date: 2014-10-27 Impact factor: 17.367
Authors: Laurel A Grisanti; Ashley A Repas; Jennifer A Talarico; Jessica I Gold; Rhonda L Carter; Walter J Koch; Douglas G Tilley Journal: Am J Physiol Heart Circ Physiol Date: 2014-12-05 Impact factor: 4.733